These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Whole-Genome Sequencing for Resistance Level Prediction in Multidrug-Resistant Tuberculosis. Li J; Yang T; Hong C; Yang Z; Wu L; Gao Q; Yang H; Tan W Microbiol Spectr; 2022 Jun; 10(3):e0271421. PubMed ID: 35658579 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the broth microdilution plate methodology for susceptibility testing of Mycobacterium tuberculosis in Peru. Puyén ZM; Santos-Lázaro D; Vigo AN; Coronel J; Alarcón MJ; Cotrina VV; Moore DAJ BMC Infect Dis; 2022 Aug; 22(1):705. PubMed ID: 36002805 [TBL] [Abstract][Full Text] [Related]
4. Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing. ; Allix-Béguec C; Arandjelovic I; Bi L; Beckert P; Bonnet M; Bradley P; Cabibbe AM; Cancino-Muñoz I; Caulfield MJ; Chaiprasert A; Cirillo DM; Clifton DA; Comas I; Crook DW; De Filippo MR; de Neeling H; Diel R; Drobniewski FA; Faksri K; Farhat MR; Fleming J; Fowler P; Fowler TA; Gao Q; Gardy J; Gascoyne-Binzi D; Gibertoni-Cruz AL; Gil-Brusola A; Golubchik T; Gonzalo X; Grandjean L; He G; Guthrie JL; Hoosdally S; Hunt M; Iqbal Z; Ismail N; Johnston J; Khanzada FM; Khor CC; Kohl TA; Kong C; Lipworth S; Liu Q; Maphalala G; Martinez E; Mathys V; Merker M; Miotto P; Mistry N; Moore DAJ; Murray M; Niemann S; Omar SV; Ong RT; Peto TEA; Posey JE; Prammananan T; Pym A; Rodrigues C; Rodrigues M; Rodwell T; Rossolini GM; Sánchez Padilla E; Schito M; Shen X; Shendure J; Sintchenko V; Sloutsky A; Smith EG; Snyder M; Soetaert K; Starks AM; Supply P; Suriyapol P; Tahseen S; Tang P; Teo YY; Thuong TNT; Thwaites G; Tortoli E; van Soolingen D; Walker AS; Walker TM; Wilcox M; Wilson DJ; Wyllie D; Yang Y; Zhang H; Zhao Y; Zhu B N Engl J Med; 2018 Oct; 379(15):1403-1415. PubMed ID: 30280646 [TBL] [Abstract][Full Text] [Related]
5. [Exploratory study on detection of drug resistance of Liu YY; Shi J; Chu P; Wu TY; Li L; Pang Y; Lu J; Guo YL Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jun; 45(6):552-559. PubMed ID: 35658379 [No Abstract] [Full Text] [Related]
6. Use of Whole-Genome Sequencing to Predict Wu X; Tan G; Sha W; Liu H; Yang J; Guo Y; Shen X; Wu Z; Shen H; Yu F Microbiol Spectr; 2022 Apr; 10(2):e0251621. PubMed ID: 35311541 [TBL] [Abstract][Full Text] [Related]
7. Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France. Genestet C; Hodille E; Berland JL; Ginevra C; Bryant JE; Ader F; Lina G; Dumitrescu O; Int J Antimicrob Agents; 2020 Apr; 55(4):105912. PubMed ID: 31991222 [TBL] [Abstract][Full Text] [Related]
8. Whole genomic sequencing as a tool for diagnosis of drug and multidrug-resistance tuberculosis in an endemic region in Mexico. Madrazo-Moya CF; Cancino-Muñoz I; Cuevas-Córdoba B; González-Covarrubias V; Barbosa-Amezcua M; Soberón X; Muñiz-Salazar R; Martínez-Guarneros A; Bäcker C; Zarrabal-Meza J; Sampieri-Ramirez C; Enciso-Moreno A; Lauzardo M; Comas I; Zenteno-Cuevas R PLoS One; 2019; 14(6):e0213046. PubMed ID: 31166945 [TBL] [Abstract][Full Text] [Related]
9. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis. Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116 [TBL] [Abstract][Full Text] [Related]
10. Accuracy of whole genome sequencing versus phenotypic (MGIT) and commercial molecular tests for detection of drug-resistant Mycobacterium tuberculosis isolated from patients in Brazil and Mozambique. Feliciano CS; Namburete EI; Rodrigues Plaça J; Peronni K; Dippenaar A; Warren RM; Silva WA; Bollela VR Tuberculosis (Edinb); 2018 May; 110():59-67. PubMed ID: 29779775 [TBL] [Abstract][Full Text] [Related]
11. Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic accuracy study. Penn-Nicholson A; Georghiou SB; Ciobanu N; Kazi M; Bhalla M; David A; Conradie F; Ruhwald M; Crudu V; Rodrigues C; Myneedu VP; Scott L; Denkinger CM; Schumacher SG; Lancet Infect Dis; 2022 Feb; 22(2):242-249. PubMed ID: 34627496 [TBL] [Abstract][Full Text] [Related]
12. Mycobacterium tuberculosis Lineages Associated with Mutations and Drug Resistance in Isolates from India. Shanmugam SK; Kumar N; Sembulingam T; Ramalingam SB; Selvaraj A; Rajendhiran U; Solaiyappan S; Tripathy SP; Natrajan M; Chandrasekaran P; Swaminathan S; Parkhill J; Peacock SJ; Ranganathan UDK Microbiol Spectr; 2022 Jun; 10(3):e0159421. PubMed ID: 35442078 [TBL] [Abstract][Full Text] [Related]
13. Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables. Kambli P; Ajbani K; Nikam C; Sadani M; Shetty A; Udwadia Z; Georghiou SB; Rodwell TC; Catanzaro A; Rodrigues C Int J Mycobacteriol; 2016 Mar; 5(1):1-6. PubMed ID: 26927983 [TBL] [Abstract][Full Text] [Related]
14. A standardised method for interpreting the association between mutations and phenotypic drug resistance in Miotto P; Tessema B; Tagliani E; Chindelevitch L; Starks AM; Emerson C; Hanna D; Kim PS; Liwski R; Zignol M; Gilpin C; Niemann S; Denkinger CM; Fleming J; Warren RM; Crook D; Posey J; Gagneux S; Hoffner S; Rodrigues C; Comas I; Engelthaler DM; Murray M; Alland D; Rigouts L; Lange C; Dheda K; Hasan R; Ranganathan UDK; McNerney R; Ezewudo M; Cirillo DM; Schito M; Köser CU; Rodwell TC Eur Respir J; 2017 Dec; 50(6):. PubMed ID: 29284687 [TBL] [Abstract][Full Text] [Related]
15. Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in Ethiopia. Mesfin EA; Merker M; Beyene D; Tesfaye A; Shuaib YA; Addise D; Tessema B; Niemann S PLoS One; 2022; 17(8):e0271508. PubMed ID: 35930613 [TBL] [Abstract][Full Text] [Related]
16. Reevaluating Rifampicin Breakpoint Concentrations for Mycobacterium tuberculosis Isolates with Disputed Wang W; Liu R; Yao C; Huo F; Shang Y; Zhang X; Wang Y; Xue Z; Ma L; Pang Y Microbiol Spectr; 2022 Feb; 10(1):e0208721. PubMed ID: 35107324 [TBL] [Abstract][Full Text] [Related]
17. Genotypic drug resistance using whole-genome sequencing of Mycobacterium tuberculosis clinical isolates from North-western Tanzania. Kidenya BR; Mshana SE; Fitzgerald DW; Ocheretina O Tuberculosis (Edinb); 2018 Mar; 109():97-101. PubMed ID: 29559127 [TBL] [Abstract][Full Text] [Related]
18. A Diagnostic Algorithm To Investigate Pyrazinamide and Ethambutol Resistance in Rifampin-Resistant Mycobacterium tuberculosis Isolates in a Low-Incidence Setting. Andres S; Gröschel MI; Hillemann D; Merker M; Niemann S; Kranzer K Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455227 [TBL] [Abstract][Full Text] [Related]
19. Development and Assessment of a Novel Whole-Gene-Based Targeted Next-Generation Sequencing Assay for Detecting the Susceptibility of Mycobacterium tuberculosis to 14 Drugs. Wu SH; Xiao YX; Hsiao HC; Jou R Microbiol Spectr; 2022 Dec; 10(6):e0260522. PubMed ID: 36255328 [TBL] [Abstract][Full Text] [Related]
20. A Rapid Drug Resistance Genotyping Workflow for Mycobacterium tuberculosis, Using Targeted Isothermal Amplification and Nanopore Sequencing. Gliddon HD; Frampton D; Munsamy V; Heaney J; Pataillot-Meakin T; Nastouli E; Pym AS; Steyn AJC; Pillay D; McKendry RA Microbiol Spectr; 2021 Dec; 9(3):e0061021. PubMed ID: 34817282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]